Gilead Sciences
GILD
#131
Rank
S$207.22 B
Marketcap
S$166.90
Share price
-0.82%
Change (1 day)
14.54%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): S$9.52

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$9.51. In 2025 the company made an earnings per share (EPS) of S$8.78 an increase over its 2024 EPS that were of S$0.49.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$9.528.45%
2025S$8.781702.63%
2024S$0.49-91.65%
2023S$5.8323.98%
2022S$4.70-25.86%
2021S$6.344850%
2020S$0.13-97.64%
2019S$5.430.9%
2018S$5.3918.71%
2017S$4.54-64.88%
2016S$12.92-18.45%
2015S$15.8455.28%
2014S$10.20296.02%
2013S$2.5817.89%
2012S$2.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.20 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.68-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.64-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.18 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.56 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$11.98 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.09-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$21.80 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.58-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA